搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
1 天
on MSN
While brand-name weight loss drugs are in short supply, a market for alternatives thrives
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
Marketplace
2 天
Generic drugs in the U.S. face new economic pressures 40 years on
The generic drug industry in the U.S. has saved people billions of dollars, but shortages are now the norm and competition is ...
WFDD
2 天
From the wilderness to the generic drug market, check out these new podcasts
Summer is sunsetting but dawn has arrived for several podcasts across public media. The NPR One team gathered a list of new ...
Medical News Today
6 天
Lipitor and cost
A generic drug is considered to be as safe and effective as the original drug. And generics tend to cost less than brand-name drugs. If your doctor has prescribed Lipitor and you’re interested ...
Opinion
The Tribune-Democrat
4 天
Opinion
David Kappos | Thank patent laws, not their critics, for generic GLP-1s
In late June, generic drug maker Teva Pharmaceuticals launched a generic version of Victoza, a blockbuster diabetes drug, in ...
Becker's Hospital Review
5 天
Sanders: Ozempic generic could cost 90% less than brand-name
Senator Bernie Sanders reveals that generic drug manufacturers can sell semaglutide, the generic of Ozempic & Wegovy, for less than $100 a month.
liberalfirst
5 天
Thank patent laws, not their critics, for generic GLP-1s
Victoza is one of the first GLP-1 drugs — the class of wildly popular diabetes and obesity treatments that includes Ozempic ...
Mississippi Valley Publishing
2 天
Fake obesity drugs are genuinely dangerous
We’re firmly in the “buyer beware” era of obesity drugs. And unfortunately, it seems like we’re going to be stuck here for a ...
ThePrint on MSN
5 天
Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir
Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to ...
2 天
on MSN
New research reveals South Africa is a global leader in affordable medicine
While some nations are burdened with exorbitant prices, others, like South Africa, have managed to keep medication costs low.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈